pharmaphorum28d
Gilead will test remdesivir in children with COVID-19
Gilead Sciences has said it will start trials soon of its antiviral drug remdesivir in children – from newborns to adolescents – who have moderate-to-severe COVID-19.
Mel Gibson Reveals Health Struggles and Controversial COVID-19 Treatment Experience
Actor Mel Gibson recently opened up about a challenging chapter in his life, sharing details of his battle with COVID-19 and ...
朝日新聞社20d
Remdesivir may be approved in Japan on May 7, health minister says
Gilead Sciences Inc.’s antiviral drug remdesivir may be approved in Japan for domestic COVID-19 patients when the health ministry’s review board is held on Thursday, Health Minister Katsunobu ...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.
Business Insider27d
NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
The ultra-broad antiviral spectrum of NV-387 ... that since remdesivir is already US FDA approved, our drug candidate encapsulating remdesivir is likely to be an approvable drug, if safety ...